When Cells Go Rogue and Become Breast Cancer
Let’s have a conversation about our bodies and learn about the why’s and how healthy cells mutate into cancer. Diva Whalen, Ph.D., Assistant Professor & Pre Health Advisor in Biology at Tougaloo College, discusses how our genetics, where we live, and stress can be major factors in how breast cancer forms, what happens once diagnosed, […]
Family Ties: Knowing Your Connection to Cancer (with MSK)
On April 20, join Memorial Sloan Kettering Cancer Center (MSK) and SHARE Cancer Support for a talk about family health history. At this talk, you will: Key Takeaways from Webinar Viewers: Learn what your family’s health history can tell you about your risk for cancer. Find out how to get genetic testing. Get helpful tips […]
When to Consider Multi-Gene Testing in Early-Stage and Metastatic Breast Cancer
You can’t change your genes, but knowing and acting on your family health history is essential for you and your medical team in developing your treatment plan. The National Comprehensive Cancer Network (NCCN) recommends genetic testing NCCN recommends genetic testing, including the BRCA1/2 genes, for all metastatic breast cancer patients because it could change treatment […]
Blood Clots and Cancer: What You Need to Know
Did you know 1 in 5 blood clots are related to cancer and its treatment? Treatments involving hospitalization, surgery, chemotherapy, and hormonal therapy can increase your blood clot risk. In collaboration with the National Blood Clot Alliance (NBCA), this program aims to inform all cancer patients about the risk of blood clots. The speaker, Jeffrey […]
Understanding the Relationship Between Estrogen and Uterine Cancer
Estrogen can play a role in uterine cancer in a number of ways. Many uterine cancer tumor types are considered to be hormonally driven, especially endometrioid tumors. Obesity is a strong risk factor as it increases and produces additional estrogen levels in our bodies. Uterine cancer treatments are evolving, and today experts can treat estrogen […]
Part I: Not all DCIS is “Risky”
Ductal carcinoma in situ (DCIS) is considered the earliest form of breast cancer and noninvasive, meaning it hasn’t spread out of the milk duct and has a low risk of becoming invasive. In part 1 of the DCIS webinar series, you will learn about different types and grades of DCIS and why that is important. […]
Cervical Chat – Early Menopause and HRT
Join the conversation with Aisha McClellan (@sharecancersupport) and Sophie Davies (@keepcalmwithsophie) as they chat about early menopause and hormone replacement therapy (HRT) following cervical cancer treatment. This program will be held on Instagram Live. https://www.youtube.com/watch?v=ZjkxcMGQOWg
Understanding Lynch Syndrome
People with Lynch syndrome have a higher risk of certain types of cancer, including endometrial, colorectal, and ovarian cancers. Heather Hampel, MS, CGC, Associate Director of the Division of Genetics and Genetic Counseling at City of Hope, will discuss genetic testing, hereditary cancer risk, prevention, and the latest updates for Lynch syndrome care. Key takeaways […]
Optimizing the Management of Early-stage TNBC: Symptoms, Treatments, and Recurrence
Triple-negative breast cancer (TNBC) accounts for about 10-15% of all breast cancers. Dr. Regina Hampton, a board-certified general surgeon with a focus on breast health and breast cancer in the DC Metro area, explains why TNBC differs from other types of invasive breast cancer, why it has fewer treatment options, and why it tends to […]